Alliance Pharma has seen profits and sales double after it acquired a range of products from rival Sinclair Pharma last year. The deal was announced in April but the company said on Tuesday that its shares had risen by more than 10 per cent since then. “Sales and profits have broadly doubled and our geographic reach extends to more than 100 countries. Alliance will now focus on developing three of its core brands — Kelo-cote, MacuShield and Diclectin — on an international level, according to Chairman Andrew Smith.
Alliance Pharma has seen profits and sales double after it acquired a range of products from rival Sinclair Pharma last year. The deal was announced in April but the company said on Tuesday that its shares had risen by more than 10 per cent since then. Alliance will now focus on developing three of its core brands — Kelo-cote, MacuShield and Diclectin — on an international level, according to Chairman Andrew Smith.